EIGER BIOPHARMACEUTICALS INC (EIGR)

US28249U2042 - Common Stock

1.725  -0.17 (-9.21%)

After market: 1.7 -0.03 (-1.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
15.77M13.48M12.14M0.000.00
Cost Of Goods
16.00K1.84M750.00KN/AN/A
Gross Profit
15.76M11.65M11.40MN/AN/A
Operating Expenses
87.53M104.38M88.33M62.15M68.90M
Research and Development
62.33M75.28M64.44M41.59M51.79M
Selling, General, and Administrative Expenses
25.20M29.11M23.90M20.56M17.11M
Operating Income
-71.78M-92.74M-76.94M-62.15M-68.90M
Interest Income/Expense
-3.26M-3.05M-3.40M-2.89M-1.33M
Other Income/Expense
87.00K140.00K46.49M-10.00K-20.00K
Non Recurring Items
-8.00K-1.10MN/AN/AN/A
Income Before Taxes
-74.96M-96.75M-33.85M-65.05M-70.25M
Income Tax
6.00K20.00K60.00KN/AN/A
Net Income
-74.96M-96.78M-33.92M-65.05M-70.25M
EBITDA
-71.50M-92.45M-76.66M-61.98M-68.83M
 
Per Share Data
EPS Diluted Total Ops
-50.78-2.32-1.00-2.31-3.08
Non GAAP EPS
N/A-18.87-2.37-2.31-3.09
 
Statistics
Gross Profit Margin
99.90%86.42%93.90%N/AN/A
Profit Margin
-475.26%-717.95%-279.41%N/AN/A
Operating Profit Margin
-455.07%-687.98%-633.77%N/AN/A

All data in USD

Charts